Health
Health is critical to our wellbeing as individuals, plays a key role in societal and economic advances, and presents many opportunities for environmental impact. Innovations in health & care allow us to alleviate suffering, increase quality of life and life expectancy, and manage the needs of a changing and ageing population.
Specialist Areas
|Sectors
|Case Studies
|Opportunities
|Case Studies
|Events
|Experts
|News
|Perspective
|Programmes
The Health sector which delivers these innovations is diverse and covers a wide range of business activities. Innovate UK KTN covers the whole sector by focusing on the broad sub sectors of Medicines, Medical Technology and Digital Health. The logic behind this focus is that each of the sub-sectors is a significant sector in its own right and has distinct characteristics. The Health team at Innovate UK KTN has considerable experience of working in these sub-sectors and of driving cross-sector working to facilitate positive change.
Our Medimap provides a dynamic representation of the UK’s end-to-end medicines supply chain covering organisations involved in the discovery, development and manufacture of medicines, as well as those supporting the sector.
Our Health Funding Map, developed with the BioIndustry Association (BIA), will help in the navigation of the complicated world of medical and health innovation funding. You can find links to, details of, and further information on many funding schemes covering a wide variety of health areas.
Our current focus in this area
Related Opportunities
SBRI: Vaccine development for potential epidemic diseases stage 1
Opens: 31/05/2023 Closes: 12/07/2023
Organisations can apply for a share of up to £25m to develop vaccine candidates, technologies and platforms, up to and including phase 1 clinical trials.
More Information
Advancing precision medicine: Round 2
Opens: 15/05/2023 Closes: 28/06/2023
Up to £20m to develop digital and data-enabled tools and multi-modal approaches for oncology, musculoskeletal/cardiovascular and chronic conditions.
More Information
Innovative technologies: Nucleic acid medicines manufacture Rd 2
Opens: 05/06/2023 Closes: 19/07/2023
UK registered organisations can apply for a share of up to £5 million for manufacturing innovation for nucleic acid medicines.
More Information
Related Events and Recordings
Thu
30
Mar
2023
Tue
16
May
2023
Tue
18
Oct
2022
Medicines Made Smarter: Data, AI, Robotics and the future of medicines manufacturing
12.00 - 13.00 | Online
Watch now
Our Experts
Related News
02/05/2023
Pilot accelerators launched to support the development of early-stage health and life science innovation in the UK
We are pleased to announce our pilot accelerators, in collaboration with the Medical Research Council (MRC), which will allow spinouts, start-ups, and entrepreneurial minded academics to test their ideas and develop concepts with support from key stakeholders from the innovation ecosystem.
Read more
28/04/2023
Exploring Microbiome Innovation: Insights from the Microbiome One Health Conference
Over 100 microbiome researchers and innovators gathered in Glasgow in March 2023 for the sold-out Microbiome One Health Conference, organised by members of the Innovate UK KTN Microbiome Innovation Advisory Board and the Health and AgriFood teams.
Read more
Programmes related to Health
Health Funding Map
The map was developed by Innovate UK KTN and the BioIndustry Association (BIA) with the help of a wide range of funders. It helps in the navigation of the complicated world of health innovation funding.
Medimap: End-to-end medicines supply chain map
Medimap is a new interactive reference tool for the UK medicines sector, mapping and categorising over 3,000 sites of organisations engaged in or supporting the end-to-end supply chain for medicines.
Neurotechnology Landscape
Neurotechnology is the application of electronics and engineering to the human nervous system and ranges from the measurement of the whole brain through technologies such as electroencephalography to the stimulation of a single nerve using bioelectronic medicines.